Peripheral Blood Leukocyte Mitochondrial DNA Content and Risk of Lung Cancer

Overview

Journal Transl Lung Cancer Res

Date 2022 Aug 12

PMID 35958326

Authors

Gregory T Kennedy

Nandita Mitra

Trevor M Penning

Alexander S Whitehead

Anil Vachani

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies of peripheral blood leukocyte mitochondrial DNA (mtDNA) content and risk of lung cancer have yielded inconsistent results, and no studies have evaluated the association between mtDNA content and post-resection lung cancer outcomes.

Methods: Using a case-control study design, we evaluated the association between mtDNA content and risk of lung cancer in 465 cases and 378 controls. We also evaluated the association between mtDNA content and survival in 189 cases with surgically resected non-small cell lung cancer (NSCLC). Relative mtDNA content was measured using a quantitative real-time polymerase chain reaction (PCR) assay in peripheral blood genomic DNA. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using multivariable logistic regression, adjusting for age, gender, race, and smoking history.

Results: mtDNA content was lower in cases compared to controls, with medians of 1.26 [interquartile range (IQR), 0.98-1.70)] and 1.79 (IQR, 1.34-2.10; P<0.001), respectively. Compared to the quartile of subjects with the highest mtDNA content, there was significantly higher likelihood of lung cancer in the second lowest quartile (OR 3.44; 95% CI: 2.06-5.75) and the lowest quartile (OR 6.36; 95% CI: 3.86-10.47). In patients with resected NSCLC, there was no association between lower mtDNA content and recurrence-free survival (RFS) [hazard ratio (HR) 0.89; 95% CI: 0.47-1.66] or overall survival (OS) (HR 0.71; 95% CI: 0.35-1.46).

Conclusions: Thus, our results counter previous studies and find that lower mtDNA content is associated with lung cancer risk. Our results suggest that mtDNA content could potentially serve as a risk biomarker, but is not associated with survival outcomes in NSCLC.

Citing Articles

Circulating mitochondrial DNA as a biomarker for lung cancer screening.

von Itzstein M, Gerber D, Minna J Transl Lung Cancer Res. 2022; 11(8):1522-1525.

PMID: 36090641 PMC: 9459621. DOI: 10.21037/tlcr-22-511.

References

Kim C, Bassig B, Seow W, Hu W, Purdue M, Huang W . Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies. Cancer Epidemiol Biomarkers Prev. 2014; 24(1):148-53. PMC: 4294971. DOI: 10.1158/1055-9965.EPI-14-0753. View

Chen J, Zhang L, Yu X, Zhou H, Luo Y, Wang W . Clinical application of plasma mitochondrial DNA content in patients with lung cancer. Oncol Lett. 2018; 16(6):7074-7081. PMC: 6256833. DOI: 10.3892/ol.2018.9515. View

Kim C, Bassig B, Seow W, Hu W, Purdue M, Shu X . Pooled analysis of mitochondrial DNA copy number and lung cancer risk in three prospective studies. Cancer Epidemiol Biomarkers Prev. 2014; 23(12):2977-80. PMC: 4257855. DOI: 10.1158/1055-9965.EPI-14-1070. View

Yang K, Forman M, Graham B, Monahan P, Giovannucci E, De Vivo I . Association between pre-diagnostic leukocyte mitochondrial DNA copy number and survival among colorectal cancer patients. Cancer Epidemiol. 2020; 68:101778. PMC: 8981089. DOI: 10.1016/j.canep.2020.101778. View

Schon E, DiMauro S, Hirano M . Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet. 2012; 13(12):878-90. PMC: 3959762. DOI: 10.1038/nrg3275. View

Lemnrau A, Brook M, Fletcher O, Coulson P, Tomczyk K, Jones M . Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer. Cancer Res. 2015; 75(14):2844-50. DOI: 10.1158/0008-5472.CAN-14-1692. View

Singh K, Ayyasamy V, Owens K, Koul M, Vujcic M . Mutations in mitochondrial DNA polymerase-gamma promote breast tumorigenesis. J Hum Genet. 2009; 54(9):516-24. PMC: 2782392. DOI: 10.1038/jhg.2009.71. View

Cote H, Gerschenson M, Walker U, Miro O, Garrabou G, Hammond E . Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey. Mitochondrion. 2011; 11(3):520-7. PMC: 3075360. DOI: 10.1016/j.mito.2011.01.011. View

Masayesva B, Mambo E, Taylor R, Goloubeva O, Zhou S, Cohen Y . Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2006; 15(1):19-24. DOI: 10.1158/1055-9965.EPI-05-0210. View

10.

Chang S, Lin P, Yang S, Wang H, Liang W, Lin J . Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis. 2009; 24(6):623-8. DOI: 10.1007/s00384-009-0663-9. View

11.

Meng S, De Vivo I, Liang L, Hu Z, Christiani D, Giovannucci E . Pre-diagnostic leukocyte mitochondrial DNA copy number and risk of lung cancer. Oncotarget. 2016; 7(19):27307-12. PMC: 5053651. DOI: 10.18632/oncotarget.8426. View

12.

Lee H, Yin P, Chi C, Wei Y . Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. J Biomed Sci. 2002; 9(6 Pt 1):517-26. DOI: 10.1007/BF02254978. View

13.

Nguyen H, LaFramboise T . Complexities and pitfalls in analyzing and interpreting mitochondrial DNA content in human cancer. J Genet Genomics. 2020; 47(7):349-359. DOI: 10.1016/j.jgg.2020.04.007. View

14.

Malik A, Czajka A . Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?. Mitochondrion. 2012; 13(5):481-92. DOI: 10.1016/j.mito.2012.10.011. View

15.

Achanta G, Sasaki R, Feng L, Carew J, Lu W, Pelicano H . Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005; 24(19):3482-92. PMC: 1276176. DOI: 10.1038/sj.emboj.7600819. View

16.

Lee H, Li S, Lin J, Wu C, Yeh D, Wei Y . Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res. 2004; 547(1-2):71-8. DOI: 10.1016/j.mrfmmm.2003.12.011. View

17.

Kulawiec M, Ayyasamy V, Singh K . p53 regulates mtDNA copy number and mitocheckpoint pathway. J Carcinog. 2009; 8:8. PMC: 2687143. DOI: 10.4103/1477-3163.50893. View

18.

Yu M, Wan Y, Zou Q . Decreased copy number of mitochondrial DNA in Ewing's sarcoma. Clin Chim Acta. 2010; 411(9-10):679-83. DOI: 10.1016/j.cca.2010.01.035. View

19.

Greaves L, Reeve A, Taylor R, Turnbull D . Mitochondrial DNA and disease. J Pathol. 2011; 226(2):274-86. DOI: 10.1002/path.3028. View

20.

Hosgood 3rd H, Liu C, Rothman N, Weinstein S, Bonner M, Shen M . Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis. 2010; 31(5):847-9. PMC: 2864414. DOI: 10.1093/carcin/bgq045. View